“BioTaiwan’s growth is a reflection of the success of Taiwan biotech as a whole in recent years”

In Taiwan, biotech is finally booming, and new companies, service providers and manufacturing facilities are emerging to fill rapidly growing industry needs. BioSpectrum Asia recently spoke to Dr. Apo Huang, Secretary General, BioTaiwan on the current growth in the Taiwanese biotech sector.

“Since the new government took office in 2016, there has been a dedicated effort to build Taiwan up to become the center of biomedical R&D in the Asia-Pacific region. Also, the much-needed infrastructure has been built; toxicology facilities, clinical batch biologics manufacturing facilities, then later CMOs and locally-set up CROs.”

Read the full interview here.


你的電子郵件位址並不會被公開。 必要欄位標記為 *